Global Anemia Drugs Market - Overview
Growing awareness and increased investment & interest towards developing drugs to combat this condition are contributing favorably to growth of the market. Since anemia significantly affects the quality of life and has also has been found as a causative factor for reducing the survival rates in cancer related cases.
Since anemia is more prevalent in women than in men, the market is majorly driven by them. Increasing rates of anemia diagnosis in pregnant women and deficiency of iron intake in diets and low levels of iron absorption level are causing expansion of the anemia drug market. Certain types of anemia types will be responsible for shaping the anemia drug industry in the forecast period.
According to a report published by Market Research Future on Global Anemia Drugs Market Research Report- Forecast to 2022 states that the global market for Anemia Drugs is worth US$21.4 billion and will grow at an estimated CAGR of 8.4% to reach US$34.7 billion at the end of forecast period by 2022.The global market for anemia drugs is demonstrating a good trend of positive growth.
Global Anemia Drugs Market – Competitive Analysis
With the entry of industry players in the anemia drug segment, a trend of solid, volume-driven growth has been observed in the market with the introduction of various types of drugs for different uses. With companies aiming to capture a considerable share of the market segment as early as possible, they are competing and experimenting with various advantage points. The best long-term growth opportunities for this sector can be captured by ensuring ongoing process improvements and financial flexibility to invest in the optimal strategies.
Some of the key players in this market are Amgen Inc., GlaxoSmithKline plc, Bluebird bio, Biocon, GlycoMimetics Inc. Some of the other prominent players are Regen biopharma Inc., Bayer AG, Acceleron Pharma, Eli Lilly and company and others.
Latest Industry News:
April 2017 Akebia Therapeutics, Inc. and Otsuka Pharmaceutical Co., Ltd. announced that they have expanded their collaboration for vadadustat by entering into a collaboration and license agreement for Europe, China and other territories. Under the terms of this collaboration agreement, Akebia will receive $208 million or more in committed capital from Otsuka, including $73 million upon signing and $135 million or more of development funding. The companies are equally sharing the costs of developing and commercializing vadadustat in the U.S., as well as the profits from potential future sales of vadadustat in the billion dollar worth renal anemia market.
Jan 2017 A first-in-class drug for anemia caused by chronic kidney disease (CKD) has been developed by FibroGen and AstraZeneca which has cleared two phase III studies in China and will be filed for approval before the end of 2017.
October 2017 Amgen Inc. has entered in an agreement to buy Kirin-Amgen, its joint venture with Japan-based Kirin Holdings Co., for $780 million. Amgen and Kyowa Hakko Kirin, the biopharmaceutical arm of Kirin, formed the 50-50 partnership in 1984 to develop Epogen, a drug used to promote the growth of red blood cells in patients with anemia.
Article source: https://article-realm.com/article/Sports-Recreation/13315-Anemia-Drugs-Market-Focuses-on-Top-Companies-Region-and-Opportunities.html
Reviews
Comments
Most Recent Articles
- Jul 5, 2024 The Evolution of sports betting online: From Tradition to Technology by Bet Ardian
- Jun 25, 2024 Strands NYT game Review by Tuan
- Jun 20, 2024 Infinite Wordle Tips and Trick by Tuan
- Jun 5, 2024 The Benefits of Using Personalized Water Bottles for Branding and Promotion by sales01
- May 27, 2024 Can Drink Bottle Manufacturers Keep Up with Sustainability Trends? by sales01
Most Viewed Articles
- 3603 hits Guide to choosing a Spa by Jaroinn Ms
- 2606 hits Generic Viagra Proving To Be an Effective Solution to Cure Erectile Dysfunction by Guest
- 1886 hits Careprost Eye Drops For Eyelashes by stella harlow
- 1763 hits The relationship between erectile dysfunction severity, mean platelet volume and vitamin D levels by John Moses
- 1653 hits Get High Potential Stamina On Bed help of Viagra by Guest
Popular Articles
In today’s competitive world, one must be knowledgeable about the latest online business that works effectively through seo services....
77365 Views
Are you caught in between seo companies introduced by a friend, researched by you, or advertised by a particular site? If that is the...
32685 Views
Walmart is being sued by a customer alleging racial discrimination. The customer who has filed a lawsuit against the retailer claims that it...
13674 Views
If you have an idea for a new product, you can start by performing a patent search. This will help you decide whether your idea could become the...
11084 Views
Statistics
Members | |
---|---|
Members: | 15316 |
Publishing | |
---|---|
Articles: | 63,054 |
Categories: | 202 |
Online | |
---|---|
Active Users: | 475 |
Members: | 0 |
Guests: | 475 |
Bots: | 5937 |
Visits last 24h (live): | 2352 |
Visits last 24h (bots): | 24604 |